Limitation of Stunning in Dog Myocardium by the Nucleoside-Nucleotide Mixture OG-VI

  • Seiichiro Kano
  • Yasunaga Okazaki
  • Tohru Nakai
  • Kumi Satoh
  • Katsuji Hoshi
  • Hideaki Kohri
  • Kazuo Ichihara
Part of the Progress in Experimental Cardiology book series (PREC, volume 1)


OG-VI improves mechanical and metabolic function in the stunned myocardium because it provides substrates for the adenine nucleotide biosynthesis. This solution can be used as an energy ameliorant for therapy of patients with ischemic heart disease.


Left Anterior Descend Saline Group Adenine Nucleotide Stun Myocardium Selective Adenosine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Braunwald E, Kloner RA. 1982. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66:1146–1149.PubMedGoogle Scholar
  2. 2.
    Kuprianov VV, Steinschneider AY, Ruuge EK, Smirnov VN, Saks VA. 1983. 31P-NMR spectrum of phosphocreatine: deuterium-induced splitting of the signal. Biochem Biophys Res Commun 114:1117–1125.CrossRefGoogle Scholar
  3. 3.
    Ichihara K, Abiko Y. 1984. Rebound recovery of myocardial creatine phosphate with reperfusion after ischemia. Am Heart J 108:1594–1597.PubMedCrossRefGoogle Scholar
  4. 4.
    Reibel DK, Rovetto MJ. 1979. Myocardial adenosine salvage rates and restoration of ATP content following ischemia. Am J Physiol 237:H247–H252.PubMedGoogle Scholar
  5. 5.
    Vary TC, Angelakos ET, Schaffer SW. 1979. Metabolism and irreversible ischemic tissue damage in isolated perfused rat heart. Circ Res 45:218–225.PubMedGoogle Scholar
  6. 6.
    Greenfield RA, Swain JL. 1987. Disruption of myofibrillar energy use: dual mechanisms that may contribute to postischemic dysfunction in stunned myocardium. Circ Res 60:283–289.PubMedGoogle Scholar
  7. 7.
    Nakai T, Kano S, Satoh K, Hoshi K, Ichihara K. 1996. Effects of adenine nucleotide analogues on myocardial dysfunction during reperfusion after ischemia in dogs. J Cardiovasc Pharmacol 28:264–270.PubMedCrossRefGoogle Scholar
  8. 8.
    Ogoshi S, Iwasa M, Mizobuchi S, Iwasa Y, Martiz A, Tamiya T. 1990. Effect of a nucleoside and nucleotide mixture on protein metabolism in rats given total parenteral nutrition after 70% hepatectomy. In Tanaka T, Okada A (eds), Nutritional Support in Organ Failure. Amsterdam: Elsevier Science, pp. 309–317.Google Scholar
  9. 9.
    Ogoshi S, Mizobuchi S, Iwasa M, Tamiya T. 1989. Effect of a nucleoside-nucleotide mixture on protein metabolism in rats after seventy percent hepatectomy. Nutrition 5:173–178.PubMedGoogle Scholar
  10. 10.
    Ogoshi S, Iwasa M, Kitagawa S, Ohmori Y, Mizobuchi S, Iwasa Y, Tamiya T. 1988. EEects of total parenteral nutrition with nucleoside and nucleotide mixture on D-galactosamine-induced liver injury in rats. J Parenter Enter Nutr 12:53–57.CrossRefGoogle Scholar
  11. 11.
    Satoh K, Nakai T, Hoshi K, Ichihara K. 1993. Limitation of stunning in dog myocardium by nucleoside and nucleotide mixture, OG-VI. Coronary Artery Dis 4:1007–1012.CrossRefGoogle Scholar
  12. 12.
    Kano S, Nakai T, Kohri H, Ichihara K. 1995. Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs. Coronary Artery Dis 6:811–818.CrossRefGoogle Scholar
  13. 13.
    Okazaki Y, Kano S, Ogoshi S, Ichihara K. 1997. Effects of OG-VI, a nucleoside/nucleotide mixture, on ischemic myocardial metabolism in dogs. Coronary Artery Dis 8:39–43.CrossRefGoogle Scholar
  14. 14.
    Jennings RB, Ganote CE. 1976. Mitochondrial structure and function in acute myocardial ischemic injury. Circ Res 38(Suppl 1):I80–I91.PubMedGoogle Scholar
  15. 15.
    Swain JL, Hines JJ, Sabina RL, Holmes EW. 1982. Accelerated repleteion of ATP and GTP pools in postischemic canine myocardium using a precursor of purine de novo synthesis. Circ Res 51:102–105.PubMedGoogle Scholar
  16. 16.
    Bolli R, Jeroudi MO, Pate1 BS, Aruoma OI, Halliwell B, Lai EK, MacCay PB. 1989. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Circ Res 65:607–622.PubMedGoogle Scholar
  17. 17.
    Bolli R. 1990. Mechanism of myocardial stunning. Circulation 82:723–738.PubMedGoogle Scholar
  18. 18.
    Martin DW Jr. 1980. Metabolism of purine and pyrimidine nucleotides. In Harper HA, Rodwell VW, Mayes PA (eds), Review of Physiological Chemistry. Los Altos: Lange Medical Publications, pp. 440–459.Google Scholar
  19. 19.
    Sabina RL, Kernstine KH, Boyd RL, Holmes EW, Swain JL. 1982. Metabolism of 5-amino-4-imidazolecarboxamide riboside in cardiac and skeletal muscle. J Biol Chem 257:10178–10183.PubMedGoogle Scholar
  20. 20.
    Miura R, Kano S, Nakai T, Satoh K, Ichihara K. 1987. Inhibitory effects of glibenclamide and pertussis toxin on the attenuation of ischemia-induced myocardial acidosis following ischemic preconditioning in dogs. Jpn Circ J 61:709–714.CrossRefGoogle Scholar
  21. 21.
    Kano S, Satoh K, Hoshi K, Ichihara K. In Press. Effects of OG-VI, a neucleoside/neucleotide mixture, on stunned Myocardium in dogs: Is the adenosine A1 receptor involved? Coronary Artery Dis 9.Google Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Seiichiro Kano
    • 1
  • Yasunaga Okazaki
    • 3
  • Tohru Nakai
    • 1
  • Kumi Satoh
    • 1
  • Katsuji Hoshi
    • 1
  • Hideaki Kohri
    • 2
  • Kazuo Ichihara
    • 4
  1. 1.Hokkaido College of PharmacyJapan
  2. 2.Nutrition Research InstituteJapan
  3. 3.Kochi Medical SchoolJapan
  4. 4.Asahikawa Medical CollegeJapan

Personalised recommendations